ECE1c promotes glioblastoma invasion via the ROCK2-MYH10 axis and interaction with ACTB

Area of Science:

• Neuro-oncology
• Molecular Biology
• Cancer Research

Background:

• Glioblastoma multiforme (GBM) is a highly aggressive primary brain tumor with significant therapeutic resistance.
• The mesenchymal subtype of GBM exhibits the highest malignancy, yet its regulatory mechanisms remain unclear.
• Understanding the molecular drivers of GBM invasion is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the role of endothelin converting enzyme 1 (ECE1) expression and its isoforms in GBM.
• To elucidate the functional significance of ECE1 in GBM cell proliferation, invasion, and overall malignancy.
• To identify the signaling pathways and molecular interactions regulated by ECE1 in GBM.

Main Methods:

• Bioinformatic analysis of ECE1 expression and prognostic value in GBM.
• In vitro studies using GBM cell lines to assess ECE1 function (knockdown and overexpression).
• In vivo xenograft models for evaluating intracranial GBM growth.
• Molecular techniques including co-immunoprecipitation, immunofluorescence, and Western blot to study protein interactions and signaling.

Main Results:

• ECE1 expression is linked to the mesenchymal subtype, CD44 expression, and poorer prognosis in GBM.
• ECE1c is the predominant isoform in GBM; its knockdown reduces GBM cell proliferation and invasion.
• Overexpression of ECE1c enhances GBM malignancy by activating the ROCK2 pathway and interacting with ACTB, promoting cytoskeletal changes and pseudopodia formation.

Conclusions:

• ECE1c acts as a critical regulator of GBM invasion through ROCK2 pathway activation and ACTB interaction.
• The modulation of cytoskeletal remodeling and pseudopodia formation by ECE1c contributes to increased GBM invasiveness.
• Targeting ECE1c presents a promising therapeutic avenue for combating invasive GBM.